Biophytis SA

General Information

(Note (a public offering): “Our ordinary shares are listed on the Euronext Growth Paris under the symbol “ALBPS.”)

We are a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases. Our goal is to become a leader in the emerging field of aging science by delivering life-changing therapies to the growing number of patients in need. To accomplish this goal, we have assembled an experienced and skilled group of industry professionals, scientists, clinicians and key opinion leaders from leading industry and academic institutions from around the world.

Employees: 30
Founded: 2006
Contact Information
Address Sorbonne University—BC 9, Bâtiment A 4ème étage 4 place Jussieu 7500,1 Paris, France
Phone Number +1 44 27 23 00
Web Address
View Prospectus: Biophytis SA
Financial Information
Market Cap $212.0mil
Revenues $0 mil (last 12 months)
Net Income $-16.6 mil (last 12 months)
IPO Profile
Symbol BPTS
Exchange NASDAQ
Shares (millions): 8.8
Price range $7.00 - $9.00
Est. $ Volume $70.0 mil
Manager / Joint Managers H.C. Wainwright & Co.
CO-Managers Invest Securities S.A.
Expected To Trade:
Status: TBA
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change